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Identification of the Molecular Target of an Inducer of Human Glioblastoma Self-Destruction 
Robin S. Bon,1 Euan S. Polson,1 Verena B. Kuchler,1 Hester A. Beard,1 Edith Ross,2 Florian 
Markowetz,2 Shoutian Zhu,3 and Heiko Wurdak1* 
Glioblastoma multiforme (GBM) is the most malignant form of brain cancer in adults with a very poor 
prognosis despite treatment. [1] The development of novel therapies for GBM is challenging due to its 
infiltrative nature, the heterogeneous and adaptive/drug-resistant character of GBM cells, and the 
blood brain barrier. [2] We discovered that the brain-penetrable small molecule KHS101 [3] selectively 
induces the self-destruction of molecularly-diverse, human patient-derived GBM cells by targeting 
specific metabolic vulnerabilities. Moreover, KHS101 is effective in orthotopic xenograft models. 
We identified the molecular target of KHS101 in GBMs through a combination of gene expression 
profiling/µFRQQHFWLYLW\mapping¶, metabolomics, and chemical proteomics. For the latter, we used a 
biologically active photo-reactive benzophenone probe (KHS101-BP). Photocrosslinking experiments 
using KHS101-BP in life cells allowed us to identify a molecular target with direct relevance to 
KHS101-induced GBM self-destruction. We subsequently developed KHS101 analogues and 
derivatives incorporating biotin or a fluorophore to enable biophysical characterisation of the 
interaction between KHS101 and its protein target. These tools may allow the development of assays 
for rapid screening/optimisation of new compounds for the treatment of GBM. 
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